AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33413354 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control, no interventions and/or exercise training
Number of subjects: 234
Study 35191210 — intervention group
Group type: EXPERIMENTAL
Intervention: Isavuconazonium sulfate (200 mg equivalent of isavuconazole) administered orally or intravenously once daily for 16 days with a loading regimen every 8 hours for the first 48 hours
Number of subjects: 76
Study 35191210 — intervention group
Group type: EXPERIMENTAL
Intervention: Isavuconazonium sulfate (100 mg, 200 mg, and 400 mg equivalent of isavuconazole) administered orally or intravenously (single ascending dose)
Number of subjects: 76
Study 33238198 — intervention group
Group type: EXPERIMENTAL
Intervention: aPDT + oral hygiene behavior (OHB)
Number of subjects: 40
Study 33238198 — intervention group
Group type: COMPARATOR
Intervention: Lingual scraper + oral hygiene behavior (OHB)
Number of subjects: 40
Study 34061052 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted interventions targeting attitude, knowledge, time, and resource barriers
Number of subjects: 20
Study 34061052 — intervention group
Group type: COMPARATOR
Intervention: Baseline audit
Number of subjects: 20
Study 35729626 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile application 'afterAMI'
Number of subjects: 100
Study 35729626 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation
Number of subjects: 100
Study 32462539 — intervention group
Group type: EXPERIMENTAL
Intervention: t‐PAPS patients
Number of subjects: 101
Study 32462539 — intervention group
Group type: EXPERIMENTAL
Intervention: t‐PAPS patients with venous thrombosis
Number of subjects: 101
Study 35442957 — intervention group
Group type: EXPERIMENTAL
Intervention: wMel intervention arm
Number of subjects: 60084
Study 35442957 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 60084
Study 35442957 — intervention group
Group type: EXPERIMENTAL
Intervention: wMel-treated arm
Number of subjects: 60084
Study 35442957 — intervention group
Group type: COMPARATOR
Intervention: Untreated arm
Number of subjects: 60084
Study 32242398 — intervention group
Group type: EXPERIMENTAL
Intervention: Qiguiyin (QGY) formula
Number of subjects: 530
Study 32242398 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 530
Study 33663731 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfemoral TAVR with the SAPIEN 3 valve
Number of subjects: 1000
Study 33663731 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 1000
Study 33552050 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant FVIII products
Number of subjects: 0
Study 33552050 — intervention group
Group type: COMPARATOR
Intervention: Plasma-derived FVIII products
Number of subjects: 0
Study 33552050 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel non-replacement therapies (including emicizumab)
Number of subjects: 0
Study 36178679 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-weekly membrane sweeping
Number of subjects: 186
Study 36178679 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-weekly membrane sweeping
Number of subjects: 186
Study 36178679 — intervention group
Group type: COMPARATOR
Intervention: Control (no membrane sweeping)
Number of subjects: 186
Study 33332933 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib plus exemestane with ovarian function suppression
Number of subjects: 178
Study 33332933 — intervention group
Group type: COMPARATOR
Intervention: Capecitabine
Number of subjects: 178
Study 33118053 — intervention group
Group type: COMPARATOR
Intervention: Pharmacological intervention
Number of subjects: 0
Study 33739618 — intervention group
Group type: EXPERIMENTAL
Intervention: SLrhEpo
Number of subjects: 39
Study 33739618 — intervention group
Group type: EXPERIMENTAL
Intervention: ALrhEpo
Number of subjects: 39
Study 33739618 — intervention group
Group type: COMPARATOR
Intervention: SLPLA
Number of subjects: 39
Study 33739618 — intervention group
Group type: COMPARATOR
Intervention: ALPLA
Number of subjects: 39
Study 33036605 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation support for family involvement and psychoeducation for 18 months
Number of subjects: 161
Study 33036605 — intervention group
Group type: COMPARATOR
Intervention: Implementation support for family involvement and psychoeducation after 18 months
Number of subjects: 161
Study 33036605 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of family involvement measures
Number of subjects: 161
Study 35969536 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted antenatal family planning information provision
Number of subjects: 246
Study 35969536 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 246
Study 34004390 — intervention group
Group type: EXPERIMENTAL
Intervention: Active video games in fully immersive virtual reality (AVR)
Number of subjects: 29
Study 34004390 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary VR (SVR)
Number of subjects: 29
Study 34004390 — intervention group
Group type: COMPARATOR
Intervention: Control (quiet sitting)
Number of subjects: 29
Study 33512805 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouth rinse
Number of subjects: 20
Study 33512805 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 20
Study 32673177 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy drink expectancies (energy enhancement, anxiety/negative physical effects, withdrawal, appetite suppression)
Number of subjects: 1246
Study 32673177 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy enhancement
Number of subjects: 1246
Study 32673177 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety/negative physical effects
Number of subjects: 1246
Study 32673177 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal
Number of subjects: 1246
Study 32673177 — intervention group
Group type: EXPERIMENTAL
Intervention: Appetite suppression
Number of subjects: 1246
Study 33775615 — intervention group
Group type: EXPERIMENTAL
Intervention: Myeloablative conditioning (MAC)
Number of subjects: 272
Study 33775615 — intervention group
Group type: COMPARATOR
Intervention: Reduced-intensity conditioning (RIC)
Number of subjects: 272
Study 32407655 — intervention group
Group type: EXPERIMENTAL
Intervention: Blocked stimuli organization
Number of subjects: 60
Study 32407655 — intervention group
Group type: COMPARATOR
Intervention: Random stimuli organization
Number of subjects: 60
Study 32407655 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory-only stimuli
Number of subjects: 60
Study 32407655 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual stimuli
Number of subjects: 60
Study 36175710 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-Assisted Laparoscopy (RAL)
Number of subjects: 369
Study 36175710 — intervention group
Group type: COMPARATOR
Intervention: Standard Laparoscopy (SL)
Number of subjects: 369
Study 34039570 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient navigation intervention
Number of subjects: 60
Study 34039570 — intervention group
Group type: COMPARATOR
Intervention: Usual care plus written information
Number of subjects: 60
Study 32162796 — intervention group
Group type: EXPERIMENTAL
Intervention: Oncologist training in shared decision making (SDM)
Number of subjects: 194
Study 32162796 — intervention group
Group type: COMPARATOR
Intervention: Patient communication aid
Number of subjects: 194
Study 32162796 — intervention group
Group type: COMPARATOR
Intervention: Combination of oncologist training and patient communication aid
Number of subjects: 194
Study 32162796 — intervention group
Group type: COMPARATOR
Intervention: Oncologist training
Number of subjects: 194
Study 35400040 — intervention group
Group type: EXPERIMENTAL
Intervention: Education group (reading leaflets)
Number of subjects: 296
Study 35400040 — intervention group
Group type: COMPARATOR
Intervention: Control group (no leaflets)
Number of subjects: 296
Study 33744393 — intervention group
Group type: EXPERIMENTAL
Intervention: Immersive virtual reality training
Number of subjects: 37
Study 33744393 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 37
Study 35947709 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic removal of small, asymptomatic kidney stones
Number of subjects: 73
Study 35947709 — intervention group
Group type: COMPARATOR
Intervention: Not removing small, asymptomatic kidney stones (control)
Number of subjects: 73
Study 33502090 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg, 25 mg)
Number of subjects: 6959
Study 35346097 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive counselling using a positive psychology approach (6 sessions of 45 minutes, 3 times a week)
Number of subjects: 60
Study 35346097 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive counselling using a positive psychology approach
Number of subjects: 60
Study 35346097 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 60
Study 33434212 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable (observational study)
Number of subjects: 843
Study 35499696 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketogenic diet (KD)
Number of subjects: 32
Study 35499696 — intervention group
Group type: COMPARATOR
Intervention: Standard diet (SD)
Number of subjects: 32
Study 35499696 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (KD and SD)
Number of subjects: 32
Study 34800034 — intervention group
Group type: EXPERIMENTAL
Intervention: IANB + IO
Number of subjects: 160
Study 34800034 — intervention group
Group type: EXPERIMENTAL
Intervention: IANB + PDL
Number of subjects: 160
Study 34800034 — intervention group
Group type: EXPERIMENTAL
Intervention: IANB + BI
Number of subjects: 160
Study 34800034 — intervention group
Group type: COMPARATOR
Intervention: IANB
Number of subjects: 160
Study 32028395 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional treatment and antimicrobial photodynamic therapy (PACT)
Number of subjects: 20
Study 32028395 — intervention group
Group type: COMPARATOR
Intervention: Conventional periodontal treatment
Number of subjects: 20
Study 33104452 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice bubbling therapy (VBT)
Number of subjects: 24
Study 33104452 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 24
Study 34634254 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose HPV vaccine
Number of subjects: 4348
Study 34634254 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-dose HPV vaccine
Number of subjects: 4348
Study 34634254 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-dose HPV vaccine
Number of subjects: 4348
Study 32739466 — intervention group
Group type: COMPARATOR
Intervention: Citalopram 20 mg/d plus 5 mL placebo syrup every 12 h
Number of subjects: 56
Study 32739466 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mL of lavender-dodder herbal syrup every 12 h plus placebo tablets once daily
Number of subjects: 56
Study 35729519 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinyl Estradiol (EE) starting at 11 years old with Growth Hormone (GH)
Number of subjects: 59
Study 35729519 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinyl Estradiol (EE) starting at 13 years old with Growth Hormone (GH)
Number of subjects: 59
Study 35729519 — intervention group
Group type: COMPARATOR
Intervention: Control group (no GH or EE until 15 years old)
Number of subjects: 59
Study 35729519 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) therapy
Number of subjects: 59
Study 35729519 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinyl Estradiol (EE) therapy
Number of subjects: 59
Study 34074296 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically elevated Lp(a)
Number of subjects: 1256
Study 32545618 — intervention group
Group type: EXPERIMENTAL
Intervention: Random Forest (RF) model
Number of subjects: 987
Study 32545618 — intervention group
Group type: COMPARATOR
Intervention: Frequency Ratio (FR) model
Number of subjects: 987
Study 34883053 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAd/m1273
Number of subjects: 1072
Study 34883053 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAd/NVX
Number of subjects: 1072
Study 34883053 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT/m1273
Number of subjects: 1072
Study 34883053 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT/NVX
Number of subjects: 1072
Study 34883053 — intervention group
Group type: COMPARATOR
Intervention: ChAd/ChAd
Number of subjects: 1072
Study 34883053 — intervention group
Group type: COMPARATOR
Intervention: BNT/BNT
Number of subjects: 1072
Study 35248120 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS combined with conventional rehabilitation therapy
Number of subjects: 100
Study 35248120 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS combined with conventional rehabilitation treatment
Number of subjects: 100
Study 35248120 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Active tDCS and Sham tDCS)
Number of subjects: 100
Study 35316221 — intervention group
Group type: EXPERIMENTAL
Intervention: UB-612 (100 µg)
Number of subjects: 3935
Study 33633221 — intervention group
Group type: EXPERIMENTAL
Intervention: Keyhole endoscopy
Number of subjects: 72
Study 33633221 — intervention group
Group type: COMPARATOR
Intervention: Large trauma craniotomy
Number of subjects: 72
Study 34510308 — intervention group
Group type: EXPERIMENTAL
Intervention: IPS intervention
Number of subjects: 720
Study 34510308 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher education
Number of subjects: 720
Study 34510308 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher cognitive function
Number of subjects: 720
Study 34510308 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher motivation to change
Number of subjects: 720
Study 34510308 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous work history
Number of subjects: 720
Study 34510308 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher age
Number of subjects: 720
Study 32778945 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin stimuli (0, 50, 100, 150, 200 μM)
Number of subjects: 32
Study 32778945 — intervention group
Group type: EXPERIMENTAL
Intervention: ALS patients (silent aspirators, PAS = 8)
Number of subjects: 32
Study 32778945 — intervention group
Group type: COMPARATOR
Intervention: Cough spirometry metrics
Number of subjects: 32
Study 35528160 — intervention group
Group type: EXPERIMENTAL
Intervention: S. boulardii in addition to BQT
Number of subjects: 180
Study 35528160 — intervention group
Group type: COMPARATOR
Intervention: BQT
Number of subjects: 180
Study 34775784 — intervention group
Group type: EXPERIMENTAL
Intervention: Finerenone
Number of subjects: 7352
Study 34775784 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7352
Study 33843602 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual Clot
Number of subjects: 35
Study 33843602 — intervention group
Group type: COMPARATOR
Intervention: Standard ROTEM tracings
Number of subjects: 35
Study 32364137 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sildenafil
Number of subjects: 0
Study 32364137 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34273231 — intervention group
Group type: EXPERIMENTAL
Intervention: Methoxyflurane
Number of subjects: 420
Study 34273231 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline plus one drop of methoxyflurane)
Number of subjects: 420
Study 33277455 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Carnitine (2 g/d orally)
Number of subjects: 46
Study 33277455 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 35872960 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing healthcare based on the theory of health behavior change integration
Number of subjects: 116
Study 35872960 — intervention group
Group type: COMPARATOR
Intervention: Common nursing
Number of subjects: 116
Study 33522981 — intervention group
Group type: EXPERIMENTAL
Intervention: Tech visits (in-person technology support visits)
Number of subjects: 129
Study 33522981 — intervention group
Group type: EXPERIMENTAL
Intervention: Tech packet (participant‐facing technology user guide)
Number of subjects: 129
Study 33522981 — intervention group
Group type: EXPERIMENTAL
Intervention: Condition-specific text message check-ins
Number of subjects: 129
Study 34153798 — intervention group
Group type: EXPERIMENTAL
Intervention: dLAN (<5 lux)
Number of subjects: 20
Study 34153798 — intervention group
Group type: COMPARATOR
Intervention: Total darkness (CON)
Number of subjects: 20
Study 32779843 — intervention group
Group type: EXPERIMENTAL
Intervention: Throat gargles (TG) sampling for CARV detection
Number of subjects: 194
Study 35236065 — intervention group
Group type: COMPARATOR
Intervention: Health resort treatment (HRT) without iodine-bromine baths (IB)
Number of subjects: 74
Study 35236065 — intervention group
Group type: EXPERIMENTAL
Intervention: Health resort treatment (HRT) with iodine-bromine baths (IB)
Number of subjects: 74
Study 35236065 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 74
Study 33608793 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse intravenous (IV) methylprednisolone (MEP) defined as ≥ 200 mg
Number of subjects: 34
Study 33608793 — intervention group
Group type: COMPARATOR
Intervention: Single ICD code for SLE
Number of subjects: 34
Study 35708633 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylsulfonylmethane (MSM) treatment
Number of subjects: 20
Study 35708633 — intervention group
Group type: EXPERIMENTAL
Intervention: Sesame seed oil (SSO) treatment
Number of subjects: 20
Study 35708633 — intervention group
Group type: EXPERIMENTAL
Intervention: MSM+SSO combination treatment
Number of subjects: 20
Study 35708633 — intervention group
Group type: COMPARATOR
Intervention: Diabetic control, no treatment
Number of subjects: 20
Study 35708633 — intervention group
Group type: EXPERIMENTAL
Intervention: All T2D treatment groups
Number of subjects: 20
Study 33819055 — intervention group
Group type: EXPERIMENTAL
Intervention: NavSTAR (Navigation Services to Avoid Rehospitalization)
Number of subjects: 400
Study 33819055 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 400
Study 35430502 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 70
Study 35430502 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 35430502 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasopressin
Number of subjects: 70
Study 34259583 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-return-to-work (PRW) medical consultation
Number of subjects: 200
Study 34259583 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic part-time (TPT) work
Number of subjects: 200
Study 34259583 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of PRW medical consultation
Number of subjects: 200
Study 34259583 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of TPT work
Number of subjects: 200
Study 34259583 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact with occupational physician
Number of subjects: 200
Study 34259583 — intervention group
Group type: EXPERIMENTAL
Intervention: Level of knowledge and use correlation
Number of subjects: 200
Study 32252976 — intervention group
Group type: EXPERIMENTAL
Intervention: Tanezumab 2.5 mg
Number of subjects: 696
Study 32252976 — intervention group
Group type: EXPERIMENTAL
Intervention: Tanezumab 2.5/5 mg
Number of subjects: 696
Study 32252976 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 696
Study 32252976 — intervention group
Group type: EXPERIMENTAL
Intervention: Tanezumab 2.5 mg and Tanezumab 2.5/5 mg
Number of subjects: 696
Study 36105683 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralaterally controlled neuromuscular electrical stimulation (CCNMES)
Number of subjects: 31
Study 36105683 — intervention group
Group type: COMPARATOR
Intervention: Neuromuscular electrical stimulation (NMES)
Number of subjects: 31
Study 32233041 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief goal-focused mentoring program (10 sessions)
Number of subjects: 67
Study 32022363 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzyme alginogel
Number of subjects: 89
Study 32022363 — intervention group
Group type: COMPARATOR
Intervention: Silver sulfadiazine (SSD)
Number of subjects: 89
Study 35705450 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid-free pathway (100 mg gabapentin TID, 15 mg ketorolac Q6 hours, 1 mg scheduled IV acetaminophen Q6 hours)
Number of subjects: 57
Study 35705450 — intervention group
Group type: COMPARATOR
Intervention: Opioid treatment (tramadol, hydrocodone-acetaminophen, or oxycodone-acetaminophen)
Number of subjects: 57
Study 32748501 — intervention group
Group type: EXPERIMENTAL
Intervention: Health coach supervised by a virtual care team
Number of subjects: 0
Study 32748501 — intervention group
Group type: COMPARATOR
Intervention: Self-directed learning group (e-platform with psychoeducational materials)
Number of subjects: 0
Study 35169917 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell-assisted autologous fat transplantation
Number of subjects: 34
Study 35169917 — intervention group
Group type: COMPARATOR
Intervention: Autologous fat transplantation alone
Number of subjects: 34
Study 33303476 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiotape of background music and positive suggestions played for 20 minutes during general anaesthesia.
Number of subjects: 385
Study 33303476 — intervention group
Group type: COMPARATOR
Intervention: Blank tape (control group).
Number of subjects: 385
Study 33303476 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiotape of background music and positive suggestions played during general anaesthesia.
Number of subjects: 385
Study 33196293 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunflower meal (SFM) supplementation
Number of subjects: 600
Study 33196293 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium and high level of crude fibre (MF and HF) diets
Number of subjects: 600
Study 33196293 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate level of crude fibre intake
Number of subjects: 600
Study 33196293 — intervention group
Group type: EXPERIMENTAL
Intervention: High level of crude fibre consumption
Number of subjects: 600
Study 34378199 — intervention group
Group type: EXPERIMENTAL
Intervention: LA ultrasound feature established by LASSO regression
Number of subjects: 0
Study 34378199 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined model including LA ultrasound feature and AF duration
Number of subjects: 0